Abstract
798 – Efficacy and Safety of Open-Label Treatment with Tofacitinib 10 Mg Twice Daily in Patients with Ulcerativ Ecolitis with Clinical Response, But Not Remission, After 52 Weeks of Maintenance Therapy: Data from the Octave Studies
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
